Evidence map›Paper›PMID 35754505›Full record

ArticleFrontiers in pharmacology2022

Adenosine-A

Hai-Ying Shen, Sadie B Baer, Raey Gesese, John M Cook, Landen Weltha, Shayla Q Coffman, Jie Wu, Jiang-Fan Chen, Ming Gao, Teng Ji

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Hai-Ying ShenDepartment of Neuroscience, Legacy Research Institute, Portland, OR, United States.
Sadie B BaerDepartment of Neuroscience, Legacy Research Institute, Portland, OR, United States.
Raey GeseseDepartment of Neuroscience, Legacy Research Institute, Portland, OR, United States.
John M CookDepartment of Neuroscience, Legacy Research Institute, Portland, OR, United States.
Landen WelthaDepartment of Neuroscience, Legacy Research Institute, Portland, OR, United States.
Shayla Q CoffmanDepartment of Neuroscience, Legacy Research Institute, Portland, OR, United States.
Jie WuDepartment of Neurobiology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, United States.
Jiang-Fan ChenMolecular Neuropharmacology Laboratory, School of Optometry and Ophthalmology and Eye Hospital, Wenzhou Medical University, Wenzhou, China.
Ming GaoDepartment of Neurobiology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, United States.
Teng JiDepartment of Pediatric Neurology, Randall Children's Hospital, Legacy Emanuel Medical Center, Portland, OR, United States.
Legacy Health · USAffiliated Eye Hospital of Wenzhou Medical College · CNBarrow Neurological Institute · USRandall Children's Hospital at Legacy Emanuel · USSt. Joseph's Hospital and Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adenosinergic activities are suggested to participate in SUDEP pathophysiology; this study aimed to evaluate the adenosine hypothesis of SUDEP and specifically the role of adenosine A

Indexed as

adenosine A2A receptoradenosine kinasebrainstemlocal field potentialNTS, nucleus tractus solitariusSUDEP (sudden unexplained death in epilepsy)

Identifiers

PMID35754505
PMCPMC9218562
OpenAlexW4285740517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.